Drug-Drug Interaction Between Colchicine and Ritonavir

Completed · Phase 1

Conditions studied: Pharmacokinetics

In brief

Ritonavir is a potent inhibitor of CYP3A4, one of the enzymes responsible for the metabolism of colchicine. This study will evaluate the effect of multiple doses of ritonavir on the pharmacokinetic profile of a single 0.6 mg dose of colchicine. A secondary objective is to evaluate the safety and tolerability of this regimen in healthy volunteers. All study subjects will be monitored for adverse events throughout the study period.

Key facts

Study ID
NCT00983515
Run by
Mutual Pharmaceutical Company, Inc.
People needed
24
Starts
2008-07-01
Expected to finish
2008-08-01
Last updated by the study team
2009-10-15

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.